Latest News for: preclinical

Edit

Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs

Nasdaq Globe Newswire 11 Feb 2026
(Ribo) and its subsidiary Ribocure Pharmaceuticals AB (Ribocure) for six preclinical small interfering RNA (siRNA) programs ... .
Edit

HPV cancer vaccine slows tumor growth, extends survival in preclinical model (Northwestern University)

Public Technologies 11 Feb 2026
) For Journalists News Releases Latest Releases News Release HPV cancer vaccine slows tumor growth, extends survival in preclinical model. Vaccine's carefully organized structure dramatically boosts cancer-fighting immunity. Link to ... Embargo date.
Edit

Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the ...

Image The Galveston Daily News 10 Feb 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Feb 10, 2026-- ....
Edit

Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting

Pharmiweb 10 Feb 2026
(NASDAQ.ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that preclinical data for EDP-978, the ...
Edit

BMI OrganBank Announces Head-to-Head Preclinical Data for OrganBank Kidney Platform

Image Reflector 09 Feb 2026
New preclinical data demonstrates reduced delayed graft function compared to hypothermic machine preservation devices, today's standard of care ... .
Edit

Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study

Image The Brunswick News 06 Feb 2026
ROCHESTER, Minn.
Edit

Preclinical Imaging Market to Reach US$ 3,332.2 Million by 2033 Driven by Rising Cell & ...

Nasdaq Globe Newswire 06 Feb 2026
The global preclinical imaging market is experiencing significant growth, propelled by increased R&D spending, ...
Edit

Barbacid Cures Pancreatic Cancer in Mice – Now Needs Funding for Humans

Greek City Times 06 Feb 2026
....
Edit

Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications

PR Newswire 05 Feb 2026
Harnessing state-of-the-art AI and automation technologies, Insilico has significantly improved the efficiency of preclinical drug development, setting a benchmark for AI-driven drug R&D.
Edit

Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment (Form 6-K) (Addex Therapeutics Ltd)

Public Technologies 03 Feb 2026
). Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment. Data published in Molecular Psychiatry. Ad Hoc Announcement Pursuant to Art. 53 LR.
Edit

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

Pharmiweb 30 Jan 2026
... the potential compatibility of the platform with GLP/GIP-based medicines, the anticipated outcomes of preclinical studies, and the potential development of future needle-free metabolic therapies.
Edit

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled ...

ACCESSWIRE 30 Jan 2026
... the potential compatibility of the platform with GLP/GIP-based medicines, the anticipated outcomes of preclinical studies, and the potential development of future needle-free metabolic therapies.
Edit

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

PR Newswire 30 Jan 2026
Across multiple preclinical models and patient-derived samples, NDL2 demonstrated reversal of immune exhaustion, suppression of metastatic biology, and enhanced anti-tumor activity, including in combination with anti-PD-1 therapy.
Edit

Up to 31.3% Body Weight Loss, Insilico Medicine Nominates AI-Powered GIPR Antagonist ISM0676 as Preclinical Candidate, Showing Synergistic Efficacy in Combination Therapy

PR Newswire 29 Jan 2026
Preclinical studies have highlighted up to 31.3% body weight loss in diet-induced obese (DIO) humanized GIPR mice when co-administered with semaglutide.
Edit

Alfa Cytology Launches Hu-Immune™ Platform to Facilitate Immunotherapy Candidate Screening and Preclinical Studies

GetNews 28 Jan 2026
Alfa Cytology launched the Hu-Immune™ platform to provide humanized mouse models and preclinical services for efficient immunotherapy screening and accelerated R&D ... screening and preclinical studies.

Article Search

tools
×
×
×
×